S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
1970’s computer coder issues shocking A.I. warning (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The Next Nvidia? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
The "Smart Money" Is Ready for May 1st Are You? (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
1970’s computer coder issues shocking A.I. warning (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The Next Nvidia? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
The "Smart Money" Is Ready for May 1st Are You? (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
1970’s computer coder issues shocking A.I. warning (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The Next Nvidia? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
The "Smart Money" Is Ready for May 1st Are You? (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
1970’s computer coder issues shocking A.I. warning (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The Next Nvidia? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
The "Smart Money" Is Ready for May 1st Are You? (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial
NASDAQ:ORMP

Oramed Pharmaceuticals (ORMP) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free ORMP Stock Alerts
$2.20
-0.13 (-5.58%)
(As of 04/18/2024 ET)
Compare
Today's Range
$2.14
▼
$2.37
50-Day Range
$2.33
▼
$3.58
52-Week Range
$1.67
▼
$5.25
Volume
240,759 shs
Average Volume
172,116 shs
Market Capitalization
$89.14 million
P/E Ratio
15.71
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media
ORMP stock logo

About Oramed Pharmaceuticals Stock (NASDAQ:ORMP)

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules for delivery of polypeptides. The company's product portfolio includes ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes, as well as in phase II clinical trial for the treatment of non-alcoholic steatohepatitis; and ORA-D-013-1 and ORA-D-013-2, which have completed phase II clinical trial for the treatment of type 2 diabetes. It has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York.

ORMP Stock Price History

ORMP Stock News Headlines

March 16, 2024 | finance.yahoo.com
ORMP Apr 2024 2.500 put
March 9, 2024 | finance.yahoo.com
Oramed Pharmaceuticals Full Year 2023 Earnings: Beats Expectations
April 18, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
February 21, 2024 | msn.com
Oramed to reinitiate pivotal type 2 diabetes trial after Phase III flop
February 20, 2024 | finanznachrichten.de
Oramed Pharmaceuticals Inc.: Oramed Letter to Shareholders
February 20, 2024 | prnewswire.com
Oramed Letter to Shareholders
January 24, 2024 | finance.yahoo.com
ORMP: Multiple Potential Applications for Proprietary Oral Protein Delivery Platform
November 28, 2023 | msn.com
Oramed Pharmaceuticals (ORMP) Price Target Increased by 36.51% to 4.39
April 18, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
November 2, 2023 | msn.com
Oramed Pharmaceuticals (ORMP) Price Target Increased by 57.50% to 3.21
October 6, 2023 | finance.yahoo.com
Oramed Pharmaceuticals (NASDAQ:ORMP) investors are sitting on a loss of 63% if they invested a year ago
September 21, 2023 | finance.yahoo.com
Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company
August 2, 2023 | finance.yahoo.com
Oramed Signs Term Sheet with HTIT to Create a Joint Venture to Advance Oral Drug Delivery Technology Globally
July 25, 2023 | jp.reuters.com
Oramed Pharmaceuticals, Inc.
June 20, 2023 | finance.yahoo.com
Oramed to Present at the 83rd American Diabetes Association Conference
June 17, 2023 | finance.yahoo.com
Oramed Pharmaceuticals (NASDAQ:ORMP) Is In A Good Position To Deliver On Growth Plans
May 30, 2023 | finance.yahoo.com
ORMP: Advancing Development Efforts in China
May 24, 2023 | markets.businessinsider.com
H.C. Wainwright Sticks to Their Hold Rating for Oramed Pharm (ORMP)
May 18, 2023 | msn.com
Canaccord Genuity Maintains Oramed Pharmaceuticals (ORMP) Hold Recommendation
May 18, 2023 | finance.yahoo.com
Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit
May 16, 2023 | msn.com
Oramed Surges on New Diabetes Treatment
May 15, 2023 | msn.com
Why Oramed Pharmaceuticals Shares Are Trading Higher Today
May 15, 2023 | finance.yahoo.com
Oramed Announces that its Chinese Partner, HTIT, has Successfully Completed a Phase 3 Oral Insulin Clinical Trial and Submitted a Marketing Authorization Application in China
May 3, 2023 | msn.com
Investing millions, Ben Shapiro joins board of Oramed Pharmaceuticals
May 2, 2023 | marketwatch.com
8-K: ORAMED PHARMACEUTICALS INC.
May 2, 2023 | finance.yahoo.com
Conservative Pundit Ben Shapiro Invests $4.7 Million in Israeli Drug Company
May 1, 2023 | finance.yahoo.com
Oramed Appoints Ben Shapiro to its Board of Directors
See More Headlines
Receive ORMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/06/2024
Today
4/18/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ORMP
CUSIP
N/A
CIK
1176309
Web
www.oramed.com
Phone
(844) 967-2633
Fax
972-2566-0004
Employees
12
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
$0.14
Trailing P/E Ratio
15.71
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$5.53 million
Net Margins
N/A
Pretax Margin
379.70%
Return on Equity
-7.15%
Return on Assets
-5.70%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.06
Quick Ratio
3.06

Sales & Book Value

Annual Sales
$1.34 million
Price / Sales
66.53
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.04 per share
Price / Book
0.54

Miscellaneous

Outstanding Shares
40,520,000
Free Float
35,657,000
Market Cap
$89.14 million
Optionable
Optionable
Beta
1.81
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

ORMP Stock Analysis - Frequently Asked Questions

How have ORMP shares performed in 2024?

Oramed Pharmaceuticals' stock was trading at $2.31 at the beginning of the year. Since then, ORMP shares have decreased by 4.8% and is now trading at $2.20.
View the best growth stocks for 2024 here.

Are investors shorting Oramed Pharmaceuticals?

Oramed Pharmaceuticals saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 583,900 shares, an increase of 20.6% from the March 15th total of 484,000 shares. Based on an average trading volume of 174,600 shares, the short-interest ratio is currently 3.3 days.
View Oramed Pharmaceuticals' Short Interest.

When is Oramed Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our ORMP earnings forecast.

How were Oramed Pharmaceuticals' earnings last quarter?

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) issued its quarterly earnings results on Wednesday, March, 6th. The biotechnology company reported ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.04.

What other stocks do shareholders of Oramed Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oramed Pharmaceuticals investors own include Compugen (CGEN), Sarepta Therapeutics (SRPT), Zynerba Pharmaceuticals (ZYNE), Inovio Pharmaceuticals (INO), Sorrento Therapeutics (SRNE), DURECT (DRRX), OPKO Health (OPK), Pluristem Therapeutics (PSTI) and Palatin Technologies (PTN).

How do I buy shares of Oramed Pharmaceuticals?

Shares of ORMP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ORMP) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
Biden replacement revealed?
Paradigm Press
The “Perfect Storm” for Gold
Gold Safe Exchange
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Your Money is Not Safe
American Alternative
The Next Nvidia?
InvestorPlace